Ocuphire Pharma Inc.

NASDAQ: OCUP · Real-Time Price · USD
1.17
-0.16 (-12.03%)
At close: Oct 23, 2024, 10:00 PM

Ocuphire Pharma Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-57.53M -9.99M 17.89M -56.69M
Depreciation & Amortization
10K 6K 4K 4K
Stock-Based Compensation
3.36M 3.51M 1.81M 1.91M
Other Working Capital
n/a 477K -3.74M -200K
Other Non-Cash Items
n/a 1.21M 170K 1.61M
Deferred Income Tax
n/a 77K n/a 33.61M
Change in Working Capital
n/a 4.08M -5.55M 181K
Operating Cash Flow
-25.58M -1.11M 14.31M -19.37M
Capital Expenditures
n/a n/a n/a -100K
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a
Other Investing Acitivies
1.21M n/a n/a -100K
Investing Cash Flow
1.21M n/a n/a -100K
Debt Repayment
n/a n/a -538K 538K
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
-311K -248K -642K -1.42M
Financial Cash Flow
4.19M 8.98M 3.79M 27.61M
Net Cash Flow
-20.18M 7.87M 18.1M 8.13M
Free Cash Flow
-25.58M -1.11M 14.31M -19.47M